Qu Biologics Inc.

Canada

 
Quantité totale PI 34
Rang # Quantité totale PI 41 738
Note d'activité PI 1,9/5.0    11
Rang # Activité PI 81 317
Classe Nice dominante Publicité; Affaires commerciales

Brevets

Marques

18 1
8 1
6 0
0
 
Dernier brevet 2024 - Personalized site-specific immun...
Premier brevet 2005 - Bacterial compositions for the t...
Dernière marque 2016 - QU BIOLOGICS
Première marque 2016 - QU BIOLOGICS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 Invention Anti-microbial immunomodulation. The invention provides methods of modulating an immune system i...
Invention Personalized site-specific immunomodulation. The invention provides methods of treating inflamma...
2022 Invention Perioperative innate immune priming in cancer therapy. Therapeutic modalities are provided invol...
Invention Perioperative innate immune priming in cancer therapy. Therapeutic modalities are provided involv...
2021 Invention Therapeutically triggering an innate immune response in a target tissue. The invention provides ...
Invention Anti-microbial immunomodulation. The invention provides methods of modulating an immune system in...
2020 Invention Tissue targeted antigenic activation of the immune response to treat cancers. The invention prov...
2018 Invention Innate targeting of adoptive cellular therapies. Therapeutic modalities are provided for targeti...
Invention Innate targeting of adoptive cellular therapies. CA 03086832 2020-06-24 (12) INTERNATIONAL APPLIC...
Invention Innate targeting of adoptive cellular therapies. Therapeutic modalities are provided for targetin...
2017 Invention Managing site specific ibd immunotherapies. Methods are provided for predicting the degree to whi...
Invention Therapeutically triggering an innate immune response in a target tissue. The invention provides t...
2016 P/S public advocacy to promote awareness of digestive diseases providing an online community forum fo...
P/S Pharmaceutical research and development; providing medical and scientific research information in...
Invention Tissue targeted antigenic activation of the immune response to treat cancers. The invention provi...
2013 Invention Tissue targeted antigenic activation of the immune response to treat cancers. E. coli cells. The ...
2012 Invention Personalized site-specific immunomodulation. The invention provides methods of treating inflammat...
Invention Immunogenic anti-inflammatory compositions. The invention provides methods of formulating an anti...
2008 Invention Tissue targeted antigenic activation of the immune response to cancers. The invention provides in...
2005 Invention Bacterial compositions for the treatment of cancer. The invention provides in part methods of tre...